CD44 has been shown to anchor the proteolytically-active form of MMP-9 to the cell surface [19] while the constitutive expression of either the transcription factor ID-1 or the receptor DDR1 has been reported to increase the activity of MMP-9 and the invasiveness of human cancer cells (35–39). This evidence concerns the gene DDR1 and cancer.